1. OP0056 The PTPN22/CSK Signalling Pathway is Involved in Susceptibility to Develop Giant Cell Arteritis. (23rd January 2014) Authors: Serrano, A.; Carmona, D.; Marquez, A.; Solans, R.; Hernández-Rodríguez, J.; Cid, M. C.; Castañeda, S.; Morado, I. C.; Narvaez, J.; Sopeña, B.; Garcia-Villanueva, M. J.; Tío-Barrera, L.; Ortego-Centeno, N.; Unzurrunzaga, A.; Marí-Alfonso, B.; Sanchez-Martin, J.; de Miguel, E.; Magro, C.; Raya, E.;... Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0127 The efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index. (12th June 2018) Authors: Dikranian, A.; Gonzalez-Gay, M. A.; Wellborne, F.; Alvaro-Gracia, J. M.; Takiya, L.; Stockert, L.; Chapman, D.; Tatulych, S.; Dahl, P.; Curtis, J. R. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗